EPA- and DHA-derived resolvins' actions in inflammatory bowel disease

European Journal of Pharmacology
Raquel Cristina SchwankeJoão B Calixto

Abstract

Inflammatory bowel diseases are chronic diseases divided into two major forms, ulcerative colitis and Crohn's disease, which are both associated with a chronic inflammatory condition of the gastrointestinal tract. Recent studies have shown that the resolution of inflammatory conditions is a biosynthetically active process where new pro-resolution lipid mediators derived from omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), such as E- and D-series resolvins, protectins, and macrophage mediator in resolving inflammation (maresins), have potent anti-inflammatory activity and serve as specialised mediators that play an important role in the resolution of inflammation. Recent studies have also shown the role of resolvins in referred hyperalgesia associated with different inflammatory processes, such as the visceral pain caused by inflammatory bowel disease. There are many reports describing the principal effects of EPA- and DHA-derived mediators in experimental models of inflammatory bowel diseases. This review focuses on the recent studies on the important role played by pro-resolution lipid mediators in controlling the inflammatory process associated with inflammatory bowel diseases.

References

Oct 1, 1992·Diseases of the Colon and Rectum·M KusunokiJ Utsunomiya
May 1, 1990·Pain·T J Ness, G F Gebhart
Oct 15, 1989·Annals of Internal Medicine·D H PresentB I Korelitz
Dec 1, 1987·Digestive Diseases and Sciences·U Klotz, K E Maier
Oct 1, 1995·Gastroenterology·C O ElsonR H Riddell
Aug 1, 1995·Clinical and Experimental Immunology·M J PalmenE P van Rees
Jan 1, 1994·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·C Talar-Williams, M C Sneller
Jan 1, 1993·Archives of Dermatological Research·K DannoS Imamura
Nov 1, 1996·International Archives of Allergy and Immunology·D RaederstorffU Moser
Oct 8, 1999·Immunity·U SteinhoffS H Kaufmann
Nov 27, 2001·Inflammatory Bowel Diseases·B ShenV W Fazio
Feb 21, 2002·Inflammatory Bowel Diseases·Daan W HommesSander J H van Deventer
Apr 16, 2002·Scientific American·Peter Libby
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Oct 3, 2002·Nature Reviews. Immunology·Toby LawrenceDerek W Gilroy
Dec 14, 2002·Journal of the American College of Nutrition·Artemis P Simopoulos
Mar 9, 2005·The Journal of Experimental Medicine·Makoto AritaCharles N Serhan
May 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Makoto AritaCharles N Serhan
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
Dec 22, 2005·Nature Immunology·Charles N Serhan, John Savill
Feb 1, 2006·PharmacoEconomics·Stefanie Maxion-BergemannRito Bergemann
Jun 17, 2006·Nature Reviews. Immunology·Göran K Hansson, Peter Libby
Jun 30, 2006·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·E M M QuigleyF Mearin
Feb 3, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles N SerhanJohn L Wallace
Mar 3, 2007·The Journal of Clinical Investigation·Warren StroberPeter Mannon
Apr 5, 2007·Nature Protocols·Stefan WirtzMarkus F Neurath
May 15, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eric L CampbellSean P Colgan
Sep 11, 2007·Advanced Drug Delivery Reviews·Stefan Wirtz, Markus F Neurath
Apr 3, 2008·American Journal of Veterinary Research·Casey J LeBlancGlenna E Mauldin
Apr 26, 2008·Nature Reviews. Immunology·Charles N SerhanThomas E Van Dyke
Jun 19, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Aksam J MerchedLawrence Chan
Dec 24, 2008·The Journal of Experimental Medicine·Charles N SerhanMatthew Spite
Mar 3, 2009·Inflammatory Bowel Diseases·Hideo Yoshida, D Neil Granger
Jun 9, 2009·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert S ChapkinDavid N McMurray

❮ Previous
Next ❯

Citations

Aug 26, 2016·Science Translational Medicine·Valerio ChiurchiùCharles N Serhan
Mar 31, 2017·Proceedings of the National Academy of Sciences of the United States of America·Thomas GobbettiMauro Perretti
Dec 28, 2016·The British Journal of Nutrition·Javier Ávila-RománVirginia Motilva
Apr 1, 2017·Scientific Reports·Ching-Shuen WangOlga J Baker
May 31, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Paula MosińskaRaquel Abalo
Feb 15, 2020·Critical Reviews in Food Science and Nutrition·Sergio DavinelliGiovanni Scapagnini
Jun 24, 2020·PloS One·Arisa YamazakiTakahisa Murata
Mar 25, 2019·Gastroenterology Research and Practice·Süleyman GünayCem Çekiç
Jul 7, 2019·Journal of Clinical Medicine·Sarah BazarganipourSabine Grösch
Oct 18, 2019·Animals : an Open Access Journal From MDPI·María RodríguezCesare Castellini
Jun 5, 2020·Clinical Reviews in Allergy & Immunology·Insha Zahoor, Shailendra Giri
Jul 31, 2018·Oxidative Medicine and Cellular Longevity·Ewa DudzińskaJanusz Kocki
Jul 9, 2020·Frontiers in Immunology·Aslıhan Avanoǧlu GülerMarco Matucci-Cerinic
Jun 24, 2018·Cancer Metastasis Reviews·Jennifer K ColbyImad Shureiqi
Nov 30, 2018·Frontiers in Immunology·Elouise E KroonErwin Schurr
Feb 13, 2018·Frontiers in Immunology·Valerio ChiurchiùMauro Maccarrone
Jan 18, 2019·Journal of Feline Medicine and Surgery·Fernanda Maria Lopes Kubitza, James Mudie George Anthony
Feb 17, 2021·Prostaglandins & Other Lipid Mediators·Md Abdur Rahman RiponMohammad Salim Hossain
Feb 20, 2021·Frontiers in Immunology·Abigail R BassonAlex Rodriguez-Palacios
Aug 15, 2017·Molecular Aspects of Medicine·Charles N SerhanJesmond Dalli
May 26, 2020·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T A Mariqueo, J Zúñiga-Hernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.